Regulacje i polityka gospodarcza · 03/10/2019

National Eye Institute to Grant Exclusive Patent License to Opsis Therapeutics for Retinal Pigment Epithelium Cell Transplant Technology

The National Eye Institute, part of the National Institutes of Health, is set to grant an exclusive patent license to Opsis Therapeutics, a biotech firm based in Madison, Wisconsin, for its innovative cell graft technology aimed at treating retinal degeneration and dysfunction.

Source: Federal Register — All DocumentsOpen original release →

Find a company or service

Business Communicator helps companies present their offer, publish updates and connect directly.

Create a company profile Explore businesses on Business Maps →

LATEST SIGNALS

Regulacje i polityka gospodarcza · 10/14/2026

Department of War Requests Comments on Proposed Manual for Courts-Martial Amendments

The Department of War (DoW) is seeking comments on proposed changes to the Manual for Courts-Martial (MCM) and has announced a public meeting to receive comments on the changes.

Read summary →